Journal:Neuropharmacology:1
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='450' side='right' scene='underdevelopment' caption=''> | <StructureSection load='' size='450' side='right' scene='underdevelopment' caption=''> | ||
===Slow-binding inhibitors of acetylcholinesterase of medical interest=== | ===Slow-binding inhibitors of acetylcholinesterase of medical interest=== | ||
| - | <big>Sofya V.Lushchekina and Patrick Masson</big> <ref>doi 10.1016/j.neuropharm.2020.108236</ref> | + | <big>Sofya V. Lushchekina and Patrick Masson</big> <ref>doi 10.1016/j.neuropharm.2020.108236</ref> |
<hr/> | <hr/> | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
Revision as of 11:12, 23 July 2020
| |||||||||||
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
